Comparative Study of the Effectiveness of Nokamen in the Prevention of Exacerbations of Chronic Recurrent Cystitis in Women
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to analyze the efficacy and safety of the use of the Nokamen phytocomplex in order to prevent exacerbations of chronic recurrent cystitis.
Materials and methods. An open mono-center comparative study was conducted in which 60 women aged 20 to 65 years old with chronic recurrent cystitis participated. In order to prevent the exacerbation of chronic recurrent cystitis, on the basis of a random sample, patients were divided into two groups. The main group (30 patients) was assigned the Nokamen phytocomplex, 1 tablet 2 times a day for 3 months. The second group (the comparison group) consisted of 30 patients who took the Pochechny herbal infusion 50 ml three times a day, also for 3 months.
Results. Analysis of the results of the observation of patients showed that the use of the Nokamen phytocomplex within 3 months after the treatment of the last episode of exacerbation of chronic cystitis significantly reduces the frequency of relapses as compared with the herbal collection. Thus, in the main group of patients taking Nokamen, exacerbation of chronic cystitis after 6 months was registered in 3 (10.0%) patients, whereas in the comparison group – in 18 (60.0%) patients.
Conclusion. The study showed that the use of the Nokamen balanced phytocomplex for 3 months compared with the herbal collection is more effective in preventing exacerbations of chronic recurrent cystitis, which allows us to recommend it for widespread use as a highly effective and safe method.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Возіанов С.О. Ресурси та основні показники діяльності урологічної служби України за 50 років / С.О. Возіанов, Н.О. Сайдакова, Л.М. Старцева // Урологія. – 2015. – № 2. – С. 9–19. Full text
Возианов А.Ф. Атлас: руководство по урологии: в 3 т. / А.Ф. Возианов, А.В. Люлько. – Днепропетровск: РИА «Днепр-VAL», 2001. – 1905 с.
Гострий неускладнений цистит у жінок. Первинна медична допомога / Під ред. С.П. Пасєчнікова // Серія «Бібліотека «Здоров’я України».– К.: ТОВ «Доктор-Медіа», 2012.– 64 с.
Пасечников С.П. Мониторинг видового спектра возбудителей инфекций мочевыводящих путей и их чувствительности к антибактериальным препаратам в урологическом отделении / С.П. Пасечников, Н.А. Сайдакова, В.С. Грицай, В.В. Кузнецов // Урологія. – 2011. – Т. 15, № 2. – С. 9–16. PDF
Пасечников С.П. Неспецифічний цистит: сучасні принципи діагностики та лікування / С.П. Пасечников, М.В. Мітченко // Здоров’я України 21 сторіччя. – 2017. – № 8 (405). – С. 50–51. PDF
Шуляк О.В. Оцінювання профілактичного потенціалу препарату Канефрон® Н у лікуванні рецидивного циститу у жінок репродуктивного віку / О.В. Шуляк, М.Є. Сабадаш // Здоровье женщины. – 2015. – № 10. – С. 51–55. PDF
Bonkat G. Guidelines EAU: guide lines on urological infections / G. Bonkat, R. Pickard, R. Bartoletti [et al.]. – 2017. – 106 p. PDF
Dingermann T., Loew D. Urologika // Phytopharmakologie. – Stuttgart. Wiss. Verlagsgesellschaft Stuttgart, 2003. – Р. 250–258.
Naber K.G. Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia // Research and Reports in Urology. – 2013. – № 5. – Р. 39–46. https://doi.org/10.2147/RRU.S39288
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North. Am. – 2014. – № 28. – P. 1–13. https://doi.org/10.1016/j.idc.2013.09.003
